Amir Vajdi

7PUBLICATIONS
98CO-AUTHORS
Molecular targetsPredictive and prognostic markersGene and molecular therapyLiquid biopsiesHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 26, 2026
Lenvatinib plus Pembrolizumab for Patients with Previously Treated Advanced Gastric, Biliary Tract, or Pancreatic Cancer: Results from the Phase II LEAP-005 Study.

Mariano Ponz-Sarvisé, Sun Young Rha, Carlos A Gomez-Roca

|Aug 01, 2025
Pembrolizumab plus axitinib versus sunitinib for advanced clear cell renal cell carcinoma: 5-year survival and biomarker analyses of the phase 3 KEYNOTE-426 trial.

Brian I Rini, Elizabeth R Plimack, Viktor Stus

|Mar 21, 2025
Genomic Landscape of Late-Stage Gastric Cancer: Analysis From KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Studies.

Yelena Y Janjigian, Michael Cecchini, Kohei Shitara

|Oct 30, 2024
Association of Tumor Mutational Burden and PD-L1 with the Efficacy of Pembrolizumab with or without Chemotherapy versus Chemotherapy in Advanced Urothelial Carcinoma.

Aude Fléchon, Rafael Morales-Barrera, Thomas Powles

|Sep 06, 2022
MET-Induced CD73 Restrains STING-Mediated Immunogenicity of EGFR-Mutant Lung Cancer.

Ryohei Yoshida, Maria Saigi, Tetsuo Tani

|Nov 23, 2021
Plasticity in the Absence of NOTCH Uncovers a RUNX2-Dependent Pathway in Small Cell Lung Cancer.

Deli Hong, Erik H Knelson, Yixiang Li

Pageof 2

Frequent Collaborators

3 joint publications

Erik H Knelson

2 joint publications

Maria Saigí

2 joint publications

Marco Campisi

2 joint publications

Patrick H Lizotte